Entries by aaron

Merck injectable version of blockbuster cancer therapy Keytruda gets USFDA approval

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph) injection for subcutaneous administration in adults across most solid tumor indications for KEYTRUDA (pembrolizumab). Berahyaluronidase alfa is a variant of human hyaluronidase developed and manufactured by […]

KGMU doctors duped of Rs 23 lakh in investment scam, FIR against 3 colleagues

Lucknow: In a recent case of fraud, resident doctors from King George’s Medical University (KGMU), Lucknow, fell victim to an elaborate multi-level marketing (MLM) scheme, losing nearly Rs 23 lakh. They have registered an FIR against three of their colleagues, accusing them of cheating by promising high returns on investment.  According to the complaint, the accused doctors […]

RIMS Ranchi hosts 3-day training on safe childbirth

Ranchi: The Rajendra Institute of Medical Sciences (RIMS), the state’s largest government hospital, is organizing a three-day special competency training programme for trainers focused on ensuring safe childbirth.  The programme is being organised by the Maternal Health Division of the National Health Mission (NHM). Specialist doctors and staff nurses from labour rooms across various districts […]

Max Healthcare and Medtronic launch advanced surgical skill lab

New Delhi: Max Healthcare, one of the largest private sector healthcare services companies in India, and Medtronic, a global leader in healthcare technology, announced the inauguration of the Max-Medtronic Skill Lab at Max Super Specialty Hospital, Saket, New Delhi. The facility is designed to advance training in minimally invasive surgical techniques and marks a significant […]

Tirzepatide Improves Blood Sugar Control in Children With Type 2 Diabetes: SURPASS-PEDS Trial

New research shows that that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in blood sugar control and weight loss in children and adolescents with type 2 diabetes aged 10-17 years whose diabetes and weight are inadequately controlled with an existing treatment regimen of metformin, insulin, or both. The study (the SURPASS-PEDS trial), by […]

Deep learning model helps in identifying the risk of complete heart block, finds JAMA

A new study published in the Journal of American Medical Association showed that patients at risk for complete heart block (CHB) may be risk-stratified using the AI-ECG model known as AIRE-CHB, which might inform therapy choices such empirical pacemaker insertion or rhythm monitoring. Ventricular standstill, syncopal damage, and abrupt cardiac death are all possible outcomes […]

Pneumococcal polysaccharide vaccine Found Ineffective in Reducing Cardiovascular Events, reports JAMA

A new study published in the Journal of American Medical Association found that pneumococcal polysaccharide vaccine (PPV23) vaccination did not reduce rates of fatal and nonfatal acute coronary syndrome or ischemic stroke. The trial was conducted at 6 centers across Australia investigated the vaccine’s cardiovascular impact. Between 2016 and 2017, this research recruited 4,725 community-dwelling adults […]

Emphysema at CT lung screening increases death risk in asymptomatic adults: Study

Emphysema detected on baseline low-dose chest CT (LDCT) in the lung cancer screening cohort of more than 9,000 asymptomatic adults was associated with death from all causes, chronic obstructive pulmonary disease (COPD), and cardiovascular disease within a 25-year follow-up period in a new study published today in Radiology, a journal of the Radiological Society of […]

Vitamin B3 Supplement Shows Promise in Cutting Skin Cancer Risk: JAMA

USA: A large Veterans Affairs (VA) cohort study has found that taking nicotinamide—a vitamin B3 derivative sold over the counter—significantly lowers the risk of developing skin cancer. The protective effect was strongest when the supplement was started soon after a patient’s first skin cancer diagnosis, according to findings published in JAMA Dermatology by Dr. Kimberly […]

Radioiodine Ablation Therapy Feasible in Hemodialysis-Dependent ESKD Patients with Low-Risk Thyroid Cancer: Case Series

Australia: In a recently published case series in BMC Nephrology, researchers from the University of Sydney, led by Dr. Raymond Lin, have demonstrated that with tailored protocols and safety precautions, radioiodine (I-131) therapy can be safely administered to patients with end-stage kidney disease (ESKD) on haemodialysis (HD) who are being treated for thyroid cancer.     […]